PHAGE: Therapy, Applications, and Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 45.5% | 0.462 | Q3 | 58.1% |
| 2024 | 1.8 | Q3 | 31.0% | 1.031 | Q1 | 85.0% |
| 2023 | 3.5 | Q2 | 56.1% | 0.877 | Q1 | 82.3% |
| 2022 | 2.7 | 32.5% | 0.581 | Q2 | 71.0% | |
| 2021 | — | — | — | 0.0% | ||
| 2020 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2641-6530
ISSN
2641-6549
country
UScoverage
2020-2026